In accordance with the agreement, Mako will become a wholly owned subsidiary of Stryker.
Mako shareholders will receive $30 per share in cash when the merger officially goes through, according to the report.
More Articles on Supply Chain Transactions:
Valeant Pharmaceuticals Acquires Solta Medical
Myco Medical, Novation Enter Private-Label Contract
MediPurpose, EKF Diagnostics Sign Private Label Deal
